Navigation Links
MGI Pharma Announces Positive Results from a Pivotal Phase 3 Study,of Aquavan Injection in Patients Undergoing Bronchoscopy

ents to recover more quickly following short surgical and diagnostic procedures and could improve facility and physician practice efficiency."

Bronchoscopy Pivotal Trial Results

A randomized, double-blind, multi-center phase 3 study was conducted to determine the safety and efficacy of Aquavan for the sedation of patients undergoing flexible bronchoscopies. Patients enrolled in this trial had medical histories that included respiratory disorders (88%), vascular disorders (55%), metabolism and nutrition disorders (55%), and infections (52%). Of all patients enrolled in the trial, 62% were found to have a pulmonary or respiratory abnormality at screening including 52% with chronic obstructive pulmonary disease (COPD) and 20% with a lung mass.

A total of 252 patients were randomized and received either a control dose of 2.0 mg/kg Aquavan or a 6.5 mg/kg dose of Aquavan. Following administration of the initial bolus dose of the study drug, the design of this trial allowed a limited number of supplemental doses to be administered to maintain sedation during the procedure.

The primary endpoint of this trial was sedation success, defined as a patient having achieved three consecutive Modified Observer's Assessment of Alertness/Sedation (MOAA/S) scores of less than or equal to 4 after administration of sedative medication and completion of the bronchoscopy procedure without the use of alternative sedative medication and without manual or mechanical ventilation. The secondary endpoint of treatment success was defined as completion of the procedure without the use of alternative sedative medication and without manual or mechanical ventilation. Additional endpoints included measures of patient satisfaction.

Among patients treated with an initial bolus dose of 6.5 mg/kg (n=150) of Aquavan, the sedation success rate was 88.7% compared to 27.5% of patients in the control arm (n=102) (p less than 0.001). The treatment success rate among patients t
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:5/29/2015)... 2015  Today, UL LLC, a global safety ... of electronic quality management systems (EQMS) and quality ... leverage the strengths of both organizations to support ... and comprehensive advice and guidance for successful global ... to UL,s strength in regulatory services and testing ...
(Date:5/29/2015)... , May 29, 2015  Anpac Bio-Medical Science Co., ... Yu and the Anpac research team are introducing ... Science (NPLS) organizers published as, "game changing" and "breakthrough" ... Society of Clinical Oncology (ASCO) Annual Meeting in ... 2, 2015. An accomplished inventor with ...
(Date:5/29/2015)...  Fair Rate Funding, a leader in TV mesh ... Delaware found Thursday that Boston Scientific,s ... organ prolapse (POP) and Stress Urinary Incontinence (SUI) in ... the design flaws from the plaintiff, Deborah Barba ... Transvaginal mesh, also known as TV mesh ...
Breaking Medicine Technology:UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 2Anpac Bio-Medical Introduces 'Game Changing' Cancer Screening Tech at American Society of Clinical Oncology Meeting - Chicago 5/29 - 6/2 3TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3
(Date:5/29/2015)... 2015 “In the current environment ... federal regulations, we provide education that will help ... are suffering from pain, within the boundaries of ... professor of rehabilitation medicine and President/Medical Director of ... Kansas. , A new flight of PAINWeekEnd Regional ...
(Date:5/29/2015)... Denver, CO (PRWEB) May 29, 2015 ... video from The Denver Foundation, community comes together to ... lead, to build neighborhoods and awareness of critical issues. ... in Metro Denver and beyond. , "What Community Does" ... oldest community foundation in Colorado, and released during the ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
(Date:5/29/2015)... May 29, 2015 The Recovery ... substance abuse, and co-occurring mental health treatment facility, ... cutting for the general public on June 1st, ... The Recovery Village at Palmer Lake will offer ... programming, utilizing traditional and evidence-based therapies, in a ...
(Date:5/29/2015)... 2015 According to a recent HealthDay article, ... workers has a substance abuse problem - the data, which ... adults with full-time jobs, revealed that 9.5% of those workers ... (1) The National Council on Alcoholism and Drug Dependence (NCAAD) ... an estimated 70% of the 14.8 million illicit drug users ...
Breaking Medicine News(10 mins):Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 2Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 3Health News:Novus Medical Detox Comments on Government Study Findings: One in 10 American Workers Struggling with Substance Abuse 4
... May 17, 2011 - It is important for health care ... public health authorities. But there is evidence of a reluctance ... concerns for both patient privacy and provider confidentiality. Dr. Khaled ... have developed a secure protocol and system that would solve ...
... 17 May 2011 There is a significant need for ... One strategy has been to determine whether physiologic ... also be useful in estimating the risk for developing this ... Swiss researchers in the current issue of Biological Psychiatry ...
... 17 May, 2011 - New analysis published by the UK ... of abortion in Poland has led to the development of ... quality of care or accountability. Since abortion became illegal in ... hospitals has fallen by 99%. The private trade in abortions ...
... A new book edited by researchers at Worcester Polytechnic ... Medicine provides a comprehensive look at the science and ... of death---heart disease. "Regenerating the Heart: Stem Cells and ... Gaudette, associate professor of biomedical engineering at WPI, and ...
... This release is available in French and ... belonging to the herpesviruses family, which also includes the herpes ... factors that might cause multiple sclerosis, a condition affecting the ... confirmed by University of Granada scientists that analyzed ...
... entrepreneur Ray Thurston decided to make a $3-million gift to ... Neurological Institute, writing a check was only part of the ... the business expertise that Thurston brought to the table. ... company he sold to UPS in 1995sat down with Nader ...
Cached Medicine News:Health News:CHEO Research Institute develops secure protocol for data disclosure 2Health News:A 'brain wave' test for schizophrenia risk? 2Health News:Abortions generate $95 million a year for Polish doctors as women use illegal private sector 2Health News:New book explores stem cell therapies for heart disease 2Health News:A virus similar to herpes could be a risk factor for multiple sclerosis 2Health News:Philanthropist connects strategic plan to research 2
... Collection Tubes are 100% plastic capillary blood ... of applications, the Capillary Collection Tubes are ... and a micro tube.,The capillary tube uses ... the micro tube thereby eliminating the tendency ...
... SAFE-T-FILL Capillary Blood Collection Tubes are 100% ... a wide range of applications, the Capillary ... tube, attached cap and a micro tube.,The ... the blood into the micro tube thereby ...
... is an enzyme immunoassay test in a microwell ... 90-minute incubation. The results are objective and ... The Bio-Rad Mumps IgG test is intended ... IgG antibodies to mumps virus in human serum ...
... for Toxoplasmosis has progressed from ... dye test to immunoflourescence, latex ... In addition to Toxo ... both Toxo IgM immunocapture and ...
Medicine Products: